Strides Pharma shares fall over 3% on plans to spin off CDMO, gelatin businesses
As per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. The consensus recommendation from 3 analysts for the stock is a 'Buy'.